From Research to Treatment: The “How,” “Why” and “Who Decides” of Cancer Research
How does scientific research turn into cancer treatments? Who is doing the research and who is funding the research? What areas of cancer research are being funded and why? What is the government’s role in funding research and directing research policy and how does that impact the development of new treatments for cancer?
Join Dr. William Dahut, the Chief Scientific Officer of the American Cancer Society, and Alice Pomponio, the Managing Director of BrightEdge, the venture capital arm of the American Cancer Society, as they walk us through the research ecosystem including: governmental vs. non-governmental driven-research and funding; the process of translating research into treatments for patients; and the relationship between public policy and the impact in fighting cancer from prevention through survivorship.
Pomponio is an expert in rare disease and precision oncology, focusing on disruptive technology adoption and diagnostic/therapeutic co-development strategies and value-based care, with an ongoing faculty role at Harvard-MIT HST Sloan Healthcare Ventures and past strategy and operational leadership roles at Radius Health, AstraZeneca, the UK Government and the US Office of Management and Budget.
Dahut is an internationally recognized physician-investigator, managing more than $400 million in research funding and guiding the American Cancer Society’s efforts to enhance and focus their research program, concentrate their priorities and working with key partners. He has authored nearly 250 publications in peer-reviewed journals and pioneered treatments in prostate and other cancers.
